2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
73
Head & Neck
60
Thoracic
33
Genitourinary
28
Gastrointestinal
27
Breast
26
Gynecologic
18
Sarcoma
17
Dermatologic
16
Endocrine
13
Lymphoid
10
Other hematologic neoplasm
7
Other solid neoplasm
4
Plasma cell
3
Myeloid
2
Other
1
NET
1
Conditions
Neuroendocrine Tumors
532
Gastro-enteropancreatic neuroendocrine tumor
58
Carcinoid Tumor
58
Neoplasms
49
Carcinoma, Neuroendocrine
44
Pancreatic Neoplasms
36
Adenoma, Islet Cell
33
Neoplasm Metastasis
28
Pheochromocytoma
26
Paraganglioma
24
Colorectal Neoplasms
24
Stomach Neoplasms
21
Breast Neoplasms
21
Prostatic Neoplasms
20
Lung Neoplasms
20
Carcinoma, Hepatocellular
20
Sarcoma
19
Carcinoma
19
Thyroid Neoplasms
18
Gastrointestinal Neoplasms
18
Neuroblastoma
15
Cholangiocarcinoma
14
Carcinoma, Renal Cell
14
Small Cell Lung Carcinoma
13
Melanoma
13
Esophageal Neoplasms
13
Serotonin Syndrome
12
Colonic Neoplasms
12
Brain Neoplasms
11
Adenocarcinoma
11
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esthesioneuroblastoma, Olfactory
×
NET
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled